PNPLA2

PNPLA2

Target · Lipid droplet lipase

PNPLA2 Patatin-like phospholipase domain-containing protein 2 · Desnutrin

PNPLA2 (patatin like domain 2, triacylglycerol lipase) is a lipase that catalyses the first step of triglyceride hydrolysis in lipid droplets. It is also known as desnutrin, ATGL, TTS-2.2, FP17548 and iPLA2zeta. Browse Assay Genie's current range of PNPLA2 research reagents below, or read on for the biology behind the target.

Lipid droplet enzymeTriglyceride lipaseLinked to neutral lipid storage disease
504 aa
Protein length
~55 kDa
Molecular weight
11p15.5
Gene locus
EC 3.1.1.3
Enzyme class
Target information

What is PNPLA2 (patatin like domain 2, triacylglycerol lipase)?

PNPLA2 catalyses the initial step in triglyceride hydrolysis in the lipid droplets of adipocytes and non-adipocytes. It shows a strong preference for long-chain fatty acid esters at the sn-2 position of the glycerol backbone and acts coordinately with LIPE/HLS and DGAT2 within the lipolytic cascade. Beyond its lipase activity, it has acylglycerol transacylase and phospholipase A2 activities. It can transfer fatty acid from triglyceride to retinol, hydrolyse retinylesters and generate 1,3-diacylglycerol from triglycerides.

The enzyme also regulates adiposome size and may contribute to adiposome degradation. In adipocytes it catalyses formation of an ester bond between hydroxy fatty acids and fatty acids derived from triglycerides or diglycerides, producing fatty acid esters of hydroxy fatty acids (FAHFAs). It acts antagonistically with LDAH in regulating cellular lipid stores and inhibits LDAH-stimulated lipid droplet fusion. PNPLA2 may be important in energy homeostasis and in the response to starvation, where enhanced triglyceride hydrolysis supplies free fatty acids to other tissues for oxidation during energy depletion.

The PNPLA2 gene belongs to the HGNC groups of lipases and patatin like phospholipase domain containing proteins. The protein localises to lipid droplets, the cell membrane and the cytoplasm. Mutations in the gene are associated with neutral lipid storage disease with myopathy. Mouse and rat orthologs are both named Pnpla2, and the protein is also referred to by its previous name, patatin-like phospholipase domain containing 2.

Lipolysis and fat metabolism

PNPLA2 catalyses the first step of triglyceride hydrolysis and works with LIPE/HLS and DGAT2 in the lipolytic cascade.

Lipid droplet biology

The enzyme regulates adiposome size and opposes LDAH, inhibiting LDAH-stimulated lipid droplet fusion and shaping cellular lipid stores.

Energy homeostasis and starvation

PNPLA2 may supply free fatty acids to other tissues for oxidation during energy depletion, making it relevant to energy balance studies.

Neutral lipid storage disease

Mutations in the PNPLA2 gene are associated with neutral lipid storage disease with myopathy, linking the enzyme to lipid storage disorders.

Background

PNPLA2 frequently asked questions

What does PNPLA2 do?

PNPLA2 catalyses the first step in triglyceride hydrolysis in adipocyte and non-adipocyte lipid droplets. It prefers long-chain fatty acid esters at the sn-2 position and acts with LIPE/HLS and DGAT2. It also has acylglycerol transacylase and phospholipase A2 activities.

What are the other names for PNPLA2?

PNPLA2 is also called desnutrin, ATGL, TTS-2.2, FP17548 and iPLA2zeta. The UniProt protein name is patatin-like phospholipase domain-containing protein 2, and the HGNC full name is patatin like domain 2, triacylglycerol lipase.

Is PNPLA2 linked to disease and conserved in rodents?

Mutations in the PNPLA2 gene are associated with neutral lipid storage disease with myopathy. Mouse and rat both carry a Pnpla2 ortholog; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other patatin-like phospholipase domain-containing proteins and lipid metabolism targets with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q96AD5; product specifications from Assay Genie datasheets.

PNPLA2 Product listing